查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790345

美国大规模和小规模生物加工市场规模、份额和趋势分析报告：按规模、工作流程、产品、应用、使用类型、模式和细分预测，2025-2033 年

U.S. Large And Small-scale Bioprocessing Market Size, Share & Trends Analysis Report By Scale, By Workflow, By Product (Bioreactors/Fermenters, Cell Culture Products), By Application, By Use-Type, By Mode, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国大规模和小规模生物加工市场概况

预计 2024 年美国大规模和小规模生物加工市场价值将达到 248.6 亿美元，到 2033 年将达到 673.4 亿美元，2025 年至 2033 年的复合年增长率为 11.24%。这一增长是由全球对单株抗体、疫苗以及细胞和基因疗法等生技药品日益增长的需求所推动的。

生物製药公司越来越多地投资于灵活的製造解决方案，例如一次性技术和模组化生物製程系统，以缩短开发时间并降低成本。

美国生物加工领域越来越多地采用一次性技术

一次性技术 (SUT) 的日益普及正在改变美国大规模和小规模生物加工市场，使其在生技药品生产中实现更高的灵活性、业务效率和成本效益。一次性系统（包括反应器、袋子、过滤器、连接器和管道）比传统的不銹钢装置越来越受欢迎，尤其是在小批量、高混合度的生产设施中。它们能够减少清洗验证、降低交叉污染风险并最大程度地缩短週转时间，非常适合现代快节奏的生物生产环境。随着个人化医疗和模组化製造需求的不断增长，SUT 在临床和商业阶段的应用都在加速。

生物製药公司和CDMO正在利用一次性技术来简化放大流程、缩短开发时间，并满足日益增长的敏捷生产需求。这些系统在早期製造阶段尤其重要，因为灵活性和速度至关重要。细胞和基因疗法通常需要小批量、高价值的生产，而这种增长进一步推动了向基于一次性技术 (SUT) 的基础设施的转变。此外，多产品生产设施的兴起需要快速切换，与传统的就地清洗系统相比，一次性组件可以更有效率地满足这项需求。

生物加工设备製造商在SUT领域不断创新，以提升性能、耐用性以及与复杂生技药品的兼容性。 γ稳定聚合物、自动化整合系统和可扩展的一次性平台等发展正在将SUT的应用范围从早期阶段扩展到商业规模。产业主要企业也在投资结合一次性系统和不銹钢系统的混合生物製程模式，以平衡成本、规模和合规性。这一趋势反映了製造商不断变化的需求，即根据批次大小、产品类型和监管要求客製化生产环境。

展望未来，美国生物加工市场中一次性使用系统 (SUT) 的成长轨迹得益于强有力的监管认可、对弹性生产设施的不断投资以及不断扩展的生技药品和先进疗法产品线。该技术能够降低资本支出、营运风险和生产停机时间，这对于下一代生物製造至关重要。随着产业持续优先考虑速度、安全性和可扩展性，一次性系统预计将在塑造美国生物加工的未来方面发挥更核心的作用。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国大规模和小规模生物加工市场的变数和趋势

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国大规模与小规模生物加工市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章美国大规模和小规模生物加工市场：规模、估值和趋势分析

  • 尺寸细分仪表板
  • 美国大规模与小规模生物加工市场规模变化分析
  • 美国大规模及小规模生物加工市场规模及趋势分析（依规模，2021-2033）
  • 工业规模（5万公升以上）
  • 小规模（小于50,000公升）

第五章美国大规模与小规模生物加工市场：依工作流程估算与趋势分析

  • 工作细分仪表板
  • 美国大规模和小规模生物加工市场的工作流程变化分析
  • 美国大规模及小规模生物加工市场规模及趋势分析（按工作流程，2021-2033）
  • 下游加工
  • 发酵
  • 上游处理

第六章：美国大规模和小规模生物加工市场（按产品、估算和趋势分析）

  • 产品细分仪表板
  • 美国大规模和小规模生物加工市场的产品差异分析
  • 美国大规模和小规模生物加工市场规模和趋势分析（按产品，2021-2033 年）
  • 反应器/发酵罐
  • 细胞培养产品
  • 过滤组件
  • 反应器配件
  • 袋子和容器
  • 其他的

第七章：美国大规模和小规模生物加工市场的应用、估计和趋势分析

  • 应用程式细分仪表板
  • 美国大规模和小规模生物加工市场应用变化分析
  • 美国大规模和小规模生物加工市场规模和趋势分析（按应用，2021-2033 年）
  • 生物製药
  • 特种工业化学品
  • 环境援助

第 8 章：美国大规模和小规模生物加工市场（按用途类型、估计和趋势分析）

  • 使用类型细分仪表板
  • 美国大规模和小规模生物加工市场使用类型变化分析
  • 美国大规模和小规模生物加工市场规模和趋势分析（按用途类型，2021-2033 年）
  • 多才多艺的
  • 一次性的

第九章美国大规模和小规模生物加工市场（按模式、估计和趋势分析）

  • 模式细分仪表板
  • 美国大规模和小规模生物加工市场的模式变异分析
  • 美国大规模及小规模生物加工市场规模及趋势分析（按模式）（2021-2033）
  • 内部
  • 外包

第十章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Danaher
    • Corning Inc.
    • Sartorius AG
    • Lonza
    • Eppendorf AG
    • Getinge AB
    • PBS BIoTech, Inc.
    • Meissner Filtration Products, Inc.
    • Entegris
    • Saint-Gobain
    • Repligen Corporation
    • Avantor, Inc
    • Distek, Inc.
    • F. Hoffmann-La Roche Ltd
    • Bio-Synthesis, Inc.
Product Code: GVR-4-68040-671-2

U.S. Large And Small-scale Bioprocessing Market Summary

The U.S. large and small-scale bioprocessing market size was estimated at USD 24.86 billion in 2024 and is projected to reach USD 67.34 billion by 2033, growing at a CAGR of 11.24% from 2025 to 2033. This growth is driven by the rising global demand for biologics, including monoclonal antibodies, vaccines, and cell and gene therapies.

Biopharmaceutical companies are increasingly investing in flexible manufacturing solutions, such as single-use technologies and modular bioprocessing systems, to accelerate development timelines and reduce costs.

Growing Adoption of Single-Use Technologies in U.S. Bioprocessing

The increasing implementation of single-use technology (SUT) is transforming the U.S. large- and small-scale bioprocessing market, enabling greater flexibility, operational efficiency, and cost-effectiveness in biologics manufacturing. Single-use systems, including bioreactors, bags, filters, connectors, and tubing, are increasingly favored over traditional stainless-steel setups, particularly for small-batch and multiproduct facilities. Their ability to reduce cleaning validation, lower the risk of cross-contamination, and minimize turnaround times makes them highly suitable for modern, fast-paced bioproduction environments. As the demand for personalized medicine and modular manufacturing grows, SUT adoption is accelerating across both clinical and commercial stages.

Biopharmaceutical companies and CDMOs are leveraging single-use technologies to streamline scale-up processes, shorten development timelines, and meet the increasing need for agile production. These systems are particularly valuable in early-stage manufacturing, where flexibility and speed are critical. The growth of cell and gene therapies, which often require small, high-value batches, is further driving the shift toward SUT-based infrastructure. Additionally, the rise of multiproduct facilities demands rapid changeovers, which are more efficiently supported by single-use components than traditional clean-in-place systems.

Manufacturers of bioprocessing equipment are continuously innovating within the SUT space to enhance performance, durability, and compatibility with complex biologics. Developments such as gamma-stable polymers, automation-integrated systems, and scalable single-use platforms are expanding the applicability of SUTs beyond early-stage production to include commercial-scale operations. Key industry players are also investing in hybrid bioprocessing models, combining single-use and stainless-steel systems, to balance cost, scale, and compliance. This trend reflects the evolving needs of manufacturers to customize production environments based on batch size, product type, and regulatory requirements.

Looking ahead, the growth trajectory of SUT in the U.S. bioprocessing market is supported by strong regulatory acceptance, increasing investment in flexible manufacturing facilities, and the expanding pipeline of biologics and advanced therapies. The technology's ability to reduce capital expenditure, operational risk, and production downtime positions it as a core enabler of next-generation biomanufacturing. As the industry continues to prioritize speed, safety, and scalability, single-use systems are expected to play an even more central role in shaping the future of bioprocessing in the U.S.

U.S. Large And Small-Scale Bioprocessing Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. large and small-scale bioprocessing market based on scale, workflow, product, application, use-type, and mode:

  • Scale Outlook (Revenue, USD Million, 2021 - 2033)
  • Industrial Scale (Over 50,000 Liter)
  • Small Scale (Less Than 50,000 Liter)
  • Workflow Outlook (Revenue, USD Million, 2021 - 2033)
  • Downstream Processing
  • Fermentation
  • Upstream Processing
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Bioreactors/Fermenters
  • Cell Culture Products
  • Filtration Assemblies
  • Bioreactors Accessories
  • Bags & Containers
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceuticals
  • Speciality Industrial Chemicals
  • Environmental Aids
  • Use-Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Multi-Use
  • Single-Use
  • Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • In-House
  • Outsourced

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Scale Segment
    • 1.2.2. Workflow Segment
    • 1.2.3. Product Segment
    • 1.2.4. Application Segment
    • 1.2.5. Use-type Segment
    • 1.2.6. Mode Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Large and Small-scale Bioprocessing Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing implementation of single-use technology for bioproduction
      • 3.2.1.2. Rising demand for biologics
      • 3.2.1.3. Expansion of contract development and manufacturing organizations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High initial setup and operational costs for large-scale bioprocessing
      • 3.2.2.2. Complexity and regulatory hurdles
  • 3.3. U.S. Large and Small-scale Bioprocessing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Large and Small-scale Bioprocessing Market: Scale Estimates & Trend Analysis

  • 4.1. Scale Segment Dashboard
  • 4.2. U.S. Large and Small-scale Bioprocessing Market Scale Movement Analysis
  • 4.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Scale, 2021 to 2033 (USD Million)
  • 4.4. Industrial Scale (Over 50,000 Liter)
    • 4.4.1. Industrial scale (Over 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Small Scale (Less Than 50,000 Liter)
    • 4.5.1. Small scale (Less Than 50,000 Liter) market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Large and Small-scale Bioprocessing Market: Workflow Estimates & Trend Analysis

  • 5.1. Workflow Segment Dashboard
  • 5.2. U.S. Large and Small-scale Bioprocessing Market Workflow Movement Analysis
  • 5.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
  • 5.4. Downstream Processing
    • 5.4.1. Downstream processing market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Fermentation
    • 5.5.1. Fermentation market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Upstream Processing
    • 5.6.1. Upstream processing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Large and Small-scale Bioprocessing Market: Product Estimates & Trend Analysis

  • 6.1. Product Segment Dashboard
  • 6.2. U.S. Large and Small-scale Bioprocessing Market Product Movement Analysis
  • 6.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 6.4. Bioreactors/Fermenters
    • 6.4.1. Bioreactors/fermenters market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Cell Culture Products
    • 6.5.1. Cell culture products market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Filtration Assemblies
    • 6.6.1. Filtration assemblies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Bioreactors Accessories
    • 6.7.1. Bioreactors accessories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Bags & Containers
    • 6.8.1. Bags & containers market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. U.S. Large and Small-scale Bioprocessing Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. U.S. Large and Small-scale Bioprocessing Market Application Movement Analysis
  • 7.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 7.4. Biopharmaceuticals
    • 7.4.1. Biopharmaceuticals market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Speciality Industrial Chemicals
    • 7.5.1. Speciality industrial chemicals market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Environmental Aids
    • 7.6.1. Environmental aids market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. U.S. Large and Small-scale Bioprocessing Market: Use-Type Estimates & Trend Analysis

  • 8.1. Use-Type Segment Dashboard
  • 8.2. U.S. Large and Small-scale Bioprocessing Market Use-Type Movement Analysis
  • 8.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Use-Type, 2021 to 2033 (USD Million)
  • 8.4. Multi-use
    • 8.4.1. Multi-use market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Single-use
    • 8.5.1. Single-use market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. U.S. Large and Small-scale Bioprocessing Market: Mode Estimates & Trend Analysis

  • 9.1. Mode Segment Dashboard
  • 9.2. U.S. Large and Small-scale Bioprocessing Market Mode Movement Analysis
  • 9.3. U.S. Large and Small-scale Bioprocessing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
  • 9.4. In-house
    • 9.4.1. In-house market estimates and forecasts 2021 to 2033 (USD Million)
  • 9.5. Outsourced
    • 9.5.1. Outsourced market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. Merck KGaA
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific, Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Danaher
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Corning Inc.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Sartorius AG
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Lonza
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Eppendorf AG
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. Getinge AB
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. PBS Biotech, Inc.
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Meissner Filtration Products, Inc.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives
    • 10.4.11. Entegris
      • 10.4.11.1. Company overview
      • 10.4.11.2. Financial performance
      • 10.4.11.3. Product benchmarking
      • 10.4.11.4. Strategic initiatives
    • 10.4.12. Saint-Gobain
      • 10.4.12.1. Company overview
      • 10.4.12.2. Financial performance
      • 10.4.12.3. Product benchmarking
      • 10.4.12.4. Strategic initiatives
    • 10.4.13. Repligen Corporation
      • 10.4.13.1. Company overview
      • 10.4.13.2. Financial performance
      • 10.4.13.3. Product benchmarking
      • 10.4.13.4. Strategic initiatives
    • 10.4.14. Avantor, Inc
      • 10.4.14.1. Company overview
      • 10.4.14.2. Financial performance
      • 10.4.14.3. Product benchmarking
      • 10.4.14.4. Strategic initiatives
    • 10.4.15. Distek, Inc.
      • 10.4.15.1. Company overview
      • 10.4.15.2. Financial performance
      • 10.4.15.3. Product benchmarking
      • 10.4.15.4. Strategic initiatives
    • 10.4.16. F. Hoffmann-La Roche Ltd
      • 10.4.16.1. Company overview
      • 10.4.16.2. Financial performance
      • 10.4.16.3. Product benchmarking
      • 10.4.16.4. Strategic initiatives
    • 10.4.17. Bio-Synthesis, Inc.
      • 10.4.17.1. Company overview
      • 10.4.17.2. Financial performance
      • 10.4.17.3. Product benchmarking
      • 10.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 U.S. Large and Small-Scale Bioprocessing Market, By Scale, 2021 - 2033 (USD Million)
  • Table 3 U.S. Large and Small-Scale Bioprocessing Market, By Workflow, 2021 - 2033 (USD Million)
  • Table 4 U.S. Large and Small-Scale Bioprocessing Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. Large and Small-Scale Bioprocessing Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 U.S. Large and Small-Scale Bioprocessing Market, By Use-Type, 2021 - 2033 (USD Million)
  • Table 7 U.S. Large and Small-Scale Bioprocessing Market, By Mode, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. large and small-scale bioprocessing market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 U.S. large and small-scale bioprocessing market: Scale outlook key takeaways
  • Fig. 13 U.S. large and small-scale bioprocessing market: Scale movement analysis
  • Fig. 14 Industrial scale market, 2021 - 2033 (USD Million)
  • Fig. 15 Small scale market, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. large and small-scale bioprocessing market: Workflow outlook key takeaways
  • Fig. 17 U.S. large and small-scale bioprocessing market: Workflow movement analysis
  • Fig. 18 Downstream processing market, 2021 - 2033 (USD Million)
  • Fig. 19 Fermentation market, 2021 - 2033 (USD Million)
  • Fig. 20 Upstream processing market, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. large and small-scale bioprocessing market: Product outlook key takeaways
  • Fig. 22 U.S. large and small-scale bioprocessing market: Product movement analysis
  • Fig. 23 Bioreactors/fermenters market, 2021 - 2033 (USD Million)
  • Fig. 24 Cell culture products market, 2021 - 2033 (USD Million)
  • Fig. 25 Filtration assemblies market, 2021 - 2033 (USD Million)
  • Fig. 26 Bioreactors accessories market, 2021 - 2033 (USD Million)
  • Fig. 27 Bags & containers market, 2021 - 2033 (USD Million)
  • Fig. 28 Others market, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. large and small-scale bioprocessing market: Application outlook and key takeaways
  • Fig. 30 U.S. large and small-scale bioprocessing market: Application movement analysis
  • Fig. 31 Biopharmaceuticals market, 2021 - 2033 (USD Million)
  • Fig. 32 Speciality industrial chemicals market, 2021 - 2033 (USD Million)
  • Fig. 33 Environmental aids market, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. large and small-scale bioprocessing market: Mode outlook key takeaways
  • Fig. 35 U.S. large and small-scale bioprocessing market: Mode movement analysis
  • Fig. 36 In-house market, 2021 - 2033 (USD Million)
  • Fig. 37 Outsourced market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. large and small-scale bioprocessing market: Use-type outlook key takeaways
  • Fig. 39 U.S. large and small-scale bioprocessing market: Use-type movement analysis
  • Fig. 40 Multi-use market, 2021 - 2033 (USD Million)
  • Fig. 41 Single-use market, 2021 - 2033 (USD Million)